I-131 Drug substance

I-131 sodium iodide solutions, drug substances supported with Active Substance Master File

 

  • Product name
    Product code
    Description
    Volume
    Radioactive concentration
    Radionuclidic purity
    Radiochemical purity
    pH
    Expiry time
    Other information
    Storage
    Packaging
  • I-131 sodium iodide sterile solution, drug substance according to European Pharmacopoeia 0281 monograph
    I-RA-7
    Clear, colourless and sterile solution of 131I sodium iodide containing iodine-131 in the form of sodium idoide in Na2CO3/NaHCO3/NaOH buffer and 0.5-2 mg/ml sodium thiosulphate solution, reducing agent diluted accoring to the cusomer specified active concentration. Bacterial endotoxins <100 IU/ml. Non-carrier added
    0.2 – 10.0 ml
    0.1 – 55.5 GBq/ml
    131I ≥ 99.9 %
    ≥ 95 %
    7 – 10
    21 days from manufacturing date
    Active pharmaceutical ingredient for manufacture of radiopharmaceuticals by dilution with water or by for capsule preparation. For oral administration.
    Store at room temperature in its own container, in accordance with the regulations on radioactive materials.
    In type I injection vial (6R or 10 R), closed with brombutyl stopper and green aluminium cap in lead container with paper insert (Type A packaging). Pack size: ≤ 29.6 GBq (at the indicated calibration date)/vial
  • I-131 sodium iodide non-sterile solution, drug substance for radiolabelling according to European Pharmacopoeia 02121 monograph
    I-RA-5
    Clear, colourless and non-sterile solution of 131I sodium iodide containing iodine-131 in the form of sodium iodide in Na2CO3/NaHCO3/NaOH buffer diluted with 0.0001M NaOH according to the customer specified active concentration. Non-carrier added. No reducing agents added.
    0.2 – 10.0 ml
    ≥ 0.1-74 GBq/ml
    131I ≥ 99.9 %
    ≥ 95 %
    8 – 11
    21 days from manufacturing date
    Active ingredient for manufacture of radiopharmaceuticals by dilution – e.g. with water or buffer for labelling purposes or capsule preparation, for oral administration.
    Store at room temperature in its own container, in accordance with the regulations on radioactive materials.
    In type I injection vial (6R or 10 R), closed with brombutyl stopper and green aluminium cap in lead container with paper insert (Type A packaging). Pack size: ≤ 111 GBq (at the indicated calibration date)/vial

Cookies help us deliver our services. By using our services, you agree to our use of cookies. More Information

Important notice

The information on these pages is intended for use only by knowledgeable and experienced professionals working in the healthcare and medical industry.

By continuing, you automatically confirm that you are a professional working for a healthcare provider in your territory.